mmunology & Cell Biology focuses on the general functioning of the immune system in its broadest sense, with a particular emphasis on its cell biology.Areas that are covered include but are not limited to: * Cellular immunology * Innate and adaptive immunity * Immune responses to pathogens * Tumour immunology * Immunopathology * Immunotherapy * Immunogenetics * Immunological studies in humans and model organisms (including mouse, rat, Drosophila etc)This leading journal has an established international reputation, built on more than 85 years of innovative publishing. The Journal publishes peer-reviewed Original Articles, Short Communications and Outstanding Observation Articles that describe new research results. Outstanding Observation Articles describe striking reproducible observations that have extremely important conceptual implications but do not necessarily include insights into the underlying molecular mechanism. This manuscript category allows publication of extraordinary findings soon after their discovery. Methodological papers or technical reports of high quality will also be considered for publication as Original Articles or Short Communications. Immunology & Cell Biology also publishes Reviews and News and Commentary articles, which provide succinct summaries of, respectively, an area or a specific research advance in immunology. Landmark articles are brief commentaries which highlight the historical significance of a particular piece of research relevant to the journal's scope. Editorial articles are brief comments written by the editor(s) of the journal or by guest editor(s) of Special Features (see below) based on the contents of the current issue or topical subjects that fall within the scope of the journal. Immunology & Cell Biology occasionally publishes Meeting Reports that briefly detail the discussions, presentations and events at a relevant recent meeting.
Immunology Letters provides a vehicle for the speedy publication of experimental papers, (mini)Reviews and Letters to the Editor addressing all aspects of molecular and cellular immunology. The essential criteria for publication will be clarity, experimental soundness and novelty. Results contradictory to current accepted thinking or ideas divergent from actual dogmas will be considered for publication provided that they are based on solid experimental findings.Preference will be given to papers of immediate importance to other investigators, either by their experimental data, new ideas or new methodology. Scientific correspondence to the Editor-in-Chief related to the published papers may also be accepted provided that they are short and scientifically relevant to the papers mentioned, in order to provide a continuing forum for discussion.Special issues:Suggestions for special issue topics and guest editors can be sent to Deirdre Dunne, d.dunne@elsevier.comBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com
Immunology and Allergy Clinics of North America updates you on the latest trends in patient management; keeps you up to date on the newest advances; and provides a sound basis for choosing treatment options. Each issue focuses on a single topic in immunology and allergy and is presented under the direction of an experienced guest editor. Topics include allergens, immunotherapy, anaphylaxis, asthma, drug allergy, eosinophilrelated disorders, food allergy, immunodeficiency states (non-HIV), basic science, mast cell disorders, rhinitis and sinusitis, and urticaria and angioedema.Immunology and Allergy Clinics of North America is published four times each year, in February, May, August, and November.
he journal Immunopharmacology and Immunotoxicology is devoted to preclinical and clinical studies about the regulatory effects of various agents on immunocompetent cells as well as the immunotoxicity exerted by xenobiotics and drugs. On these bases, the journal encompasses a broad range of pathologies (e.g., acute and chronic infections, allergy, autoimmunity, cancer, degenerative disorders, inflammation and primary and secondary immunodeficiencies).In this framework, the journal will cover new emerging areas of science of broad interest, such as agricultural biotechnology; atherosclerosis; cytokine and growth factor regulation; dendritic cell therapy; food immunology and safety; forensic immunopathology; innate immunity regulation; microbial immunomodulators; mucosal immunity; drug development; psychoneuroimmunology; stem cell therapy; veterinary immunopathology; and vaccines. While articles related to purified extracts may be considered, research on crude botanical extracts are discouraged.Immunopharmacology and Immunotoxicology will accept original manuscripts, brief communications, invited reviews, and clinical cases, on the condition that the results reported are based on original, clinical, or basic research that has not been published elsewhere in any journal in any language (except in abstract form relating to paper communicated to scientific meetings and symposiums).Read More: http://informahealthcare.com/page/ipi/Description.
Immunotherapy offers the scientific community an interdisciplinary forum, providing them with the most recent advances of various aspects of immunotherapeutics to aid navigation of this complex field. Immunotherapy delivers essential information in concise, at-a-glance article formats. Key advances in the field are reported and analyzed by international experts, providing an authoritative but accessible forum for this vitally important area of research
Implementation Science is ready to receive manuscripts that research methods to promote the uptake of research findings into routine healthcare.
Implementation Science Communications is an inclusive and multidisciplinary journal, welcoming studies on strategies across the implementation continuum – from planned implementation to evaluations of implementation efforts and natural experiments to planned de-implementation of practices without clear evidence of benefit. research.